chatGPT says:
Without Advent’s licence(UK MIA 54923 is a manufacturing licence):
The MAA cannot be approved
At best, it would be conditionally paused
So the MIA is supporting infrastructure for the application already under review.
For Northwest Biotherapeutics (NWBO), this means:
Advent is legally authorised by MHRA to manufacture human cell-based medicinal products (like DCVax-L)
The Sawston facility is GMP-compliant and inspection-approved
DCVax-L can be manufactured there for commercial supply once the product itself is approved
👉 This is a prerequisite, not an outcome.